PBE
Invesco Biotechnology & Genome ETF · Financial Services
78.40
0.57%(-0.45)
Market OpenLast Updated: — ET
52W L: $54.5252W H: $85.73
$78.40
CHG+0.47 (+0.60%)
H$80.14
L$75.50
VOL229K
PBE (1h)
Invesco Biotechnology & Genome ETF · Financial Services
The Invesco Biotechnology & Genome ETF (PBE) was launched on June 23, 2005, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of the equity market.
The Invesco Biotechnology & Genome ETF (PBE) was launched on 06/23/2005, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.
The Invesco Biotechnology & Genome ETF (PBE) was launched on June 23, 2005, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of the equity market.
No recent filings